Details for 2016749691
Up to date per 04.04.2026
Actions
Details for 2016749691
Deleted
European Patent
20.12.2017 A
05.08.2020 B1
09.02.2015
US
201562113943 P
10.04.2015
US
201562145770 P
21.04.2015
US
201562150679 P
A61K 38/22 20060101AFI20180713BHEP
Owner
Phasebio Pharmaceuticals, Inc.One Great Valley Parkway Suite 30 Malvern, Pennsylvania 19355US
Representative
No representatives present
Inventor
GEORGOPOULOS, Lynnec/o Phasebio Pharmaceuticals Inc. One Great Valley Parkway Suite 30 Malvern, Pennsylvania 19355US
ARNOLD, Susanc/o Phasebio Pharmaceuticals Inc. One Great Valley Parkway Suite 30 Malvern, Pennsylvania 19355US
BALLANCE, David Jamesc/o Phasebio Pharmaceuticals Inc. One Great Valley Parkway Suite 30 Malvern, Pennsylvania 19355US